Tag Archive: CTL019

May 19 2017

Sports Medicine Research Award, Concussion Research Collaboration, Stephan Grupp, PAS Meeting, Type 1.5 Diabetes

Our latest research news roundup carries a hint of summer and exciting new beginnings.

Permanent link to this article: http://blog.research.chop.edu/in-the-news-sports-medicine-research-award-concussion-research-collaboration-stephen-grupp-pas-meeting-type-1-5-diabetes/

Dec 30 2016

CHOP Research In the News: Rose Bowl Parade, Asthma, Cardiac Imaging, Pediatric Leukemia, Immune Response

The end of the year has come up fast, and so have important advances in pediatric research at Children’s Hospital of Philadelphia. This week’s In the News starts off with a celebration of two remarkable patients and their dedicated pediatric oncologist.

Permanent link to this article: http://blog.research.chop.edu/chop-research-news-rose-bowl-parade-asthma-cardiac-imaging-pediatric-leukemia-immune-response/

Dec 16 2016

CHOP Research In the News: Global Trial of CTL019, Gene Therapy for Hemophilia, Child Abuse Within Military, New Radiologist-in-Chief, ADHD in Preschool

Your holiday season has been hectic, no doubt. Catch up with an early gift from us: Our biweekly roundup of research news from Children’s Hospital of Philadelphia comes with all the trimmings!

Permanent link to this article: http://blog.research.chop.edu/chop-research-news-global-trial-ctl019-gene-therapy-hemophilia-child-abuse-within-military-new-radiologist-chief-adhd-preschool/

Jun 10 2016

CHOP Research In the News: Clinical Research in the Spotlight

We like to highlight the whole range of research at The Children’s Hospital of Philadelphia, from basic discoveries at the lab bench to clinical findings applied at the patient’s bedside. But we have an abundance of updates to share today about the clinical side of research.

Permanent link to this article: http://blog.research.chop.edu/chop-research-news-clinical-research-spotlight/

Dec 08 2015

Latest Findings Add Insight Into Targeted Cancer Immunotherapy

Researchers at The Children’s Hospital of Philadelphia reported their latest results from their studies of an investigational personalized cell therapy for a highly aggressive form of cancer, acute lymphoblastic leukemia (ALL).

Permanent link to this article: http://blog.research.chop.edu/latest-findings-add-insight-into-targeted-cancer-immunotherapy/

Sep 17 2015

Teaching the Immune System to Have Long-term Memory for Leukemia

Your immune system is designed to protect against foreign invaders such as infections, but you may not realize that it also destroys abnormal cells that your body produces.

Permanent link to this article: http://blog.research.chop.edu/teaching-the-immune-system-to-have-long-term-memory-for-leukemia/

Mar 30 2015

Watch CANCER: THE EMPEROR OF ALL MALADIES

The history of our understanding and approach to cancer are at the center of CANCER: THE EMPEROR OF ALL MALADIES, a film directed by Barak Goodman and executive produced by Ken Burns. The documentary, which features the Cancer Center at CHOP, will air in three parts on March 30, 31 and April 1 at 9 …

Continue reading »

Permanent link to this article: http://blog.research.chop.edu/watch-cancer-the-emperor-of-all-maladies/

Dec 19 2014

Benefits Persist in T Cell Therapy for Children with Relapsed Leukemia

An innovative cell therapy for this stubborn form of leukemia continues to show highly promising results in children treated in a pilot clinical trial.

Permanent link to this article: http://blog.research.chop.edu/benefits-persist-t-cell-therapy-children-relapsed-leukemia/

Oct 20 2014

T-Cell Therapy Leads to Remission in 90 Percent of Leukemia Patients

A landmark new study published in the New England Journal of Medicine shows that 90 percent of leukemia patients treated with a groundbreaking form of cellular therapy achieved complete responses.

Permanent link to this article: http://blog.research.chop.edu/hope-springs-t-cell-therapy-leads-remission-90-percent-leukemia-patients/

May 06 2014

Blocking Paths to Resistance to T Cell Therapy for B-ALL

CHOP’s Center for Childhood Cancer Research (CCCR), has begun a unique collaboration that will contribute to scientific understanding of how immunotherapy can improve the survival of children with B cell acute lymphoblastic leukemia (B-ALL) that resists standard therapy.

Permanent link to this article: http://blog.research.chop.edu/blocking-paths-resistance-t-cell-therapy-b/

Older posts «